Mohamed E. El‐Beeh

Mohamed E. El‐Beeh


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Mohamed O. RadwanMohamed O. Radwan
Mohamed O. Radwan
Howaida Ibrahim Abd-AllaHowaida Ibrahim Abd-Alla
Howaida Ibrahim Abd-Alla
HEHatem Elmezayen
Hatem Elmezayen
MAMohammed Abdelwahab Sayed Abourehab
Mohammed Abdelwahab Sayed Abourehab
MEMohamed E. El‐Beeh
Mohamed E. El‐Beeh
Mikako FujitaMikako Fujita
Mikako Fujita
In the last decade, gypsogenin has widely grabbed the attention of medicinal chemists by virtue of its prominent anti-cancer potential. Despite its late identification, gypsogenin proved itself as a new an-ti-proliferative player battling for a front position among other classic pentacyclic triterpenes such as oleanolic acid, glycyrrhetinic acid, ursolic acid, betulinic acid, and celastrol. Herein, we present insights into the anti-cancer activity of gypsogenin and its semisynthetic derivatives and go further by introducing our perspective to judiciously guide the prospect rational design. The present article opens a new venue for better exploitation of gypsogenin chemical entity as a lead compound in cancer chemotherapy. To the best of our knowledge, this is the first review article exploring the anti-cancer activity of gypsogenin derivatives.